Targeting epigenetic regulators to overcome drug resistance in cancers
N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …
regulation is a heritable change in gene expressions independent of nucleotide sequence …
Small cell lung cancer transformation: From pathogenesis to treatment
X Yin, Y Li, H Wang, T Jia, E Wang, Y Luo, Y Wei… - seminars in Cancer …, 2022 - Elsevier
Small cell lung cancer (SCLC) is a type of neuroendocrine tumor with high malignancy and
poor prognosis. Besides the de novo SCLC, there is transformed SCLC, which has similar …
poor prognosis. Besides the de novo SCLC, there is transformed SCLC, which has similar …
The mechanism of DNA methylation and miRNA in breast cancer
L Ma, C Li, H Yin, J Huang, S Yu, J Zhao… - International Journal of …, 2023 - mdpi.com
Breast cancer is the most prevalent cancer in the world. Currently, the main treatments for
breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment …
breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment …
Recent progress of biosensors for the detection of lung cancer markers
Lung cancer is one of the most common cancers worldwide and the leading cause of death.
Early screening of lung cancer is exceptionally essential for later treatment. Abnormal lung …
Early screening of lung cancer is exceptionally essential for later treatment. Abnormal lung …
Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
J Zhu, R Huang, R Yang, Y Xiao, J Yan, C Zheng… - Cancer cell …, 2021 - Springer
Background Targeting tumor microenvironment (TME) may provide therapeutic activity and
selectivity in treating cancers. Therefore, an improved understanding of the mechanism by …
selectivity in treating cancers. Therefore, an improved understanding of the mechanism by …
[HTML][HTML] Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
H Luo, J Shan, H Zhang, G Song, Q Li, CX Xu - Seminars in Cancer Biology, 2022 - Elsevier
Dysregulation of the epigenetic processes, such as DNA methylation, histone modifications,
and modulation of chromatin states, drives aberrant transcription that promotes initiation and …
and modulation of chromatin states, drives aberrant transcription that promotes initiation and …
[PDF][PDF] Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer.
J Shi, Y Chen, C Peng, L Kuang, Z Zhang… - … (Tech Science Press), 2022 - researchgate.net
The incidence and mortality of lung cancer rank top three of all cancers worldwide.
Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) …
Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) …
HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism
J Cui, F Xu, W Bai, T Zhao, J Hong, W Zuo - Journal of Translational …, 2023 - Springer
Background Histone deacetylases (HDAC) contribute to oncogenic program, pointing to
their inhibitors as a potential strategy against cancers. We, thus, studied the mechanism of …
their inhibitors as a potential strategy against cancers. We, thus, studied the mechanism of …
Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease Biomarkers
M Agostini, P Traldi, M Hamdan - Medicina, 2023 - mdpi.com
Mass spectrometry-based proteomics is a key player in research efforts to characterize
aberrant epigenetic alterations, including histone post-translational modifications and DNA …
aberrant epigenetic alterations, including histone post-translational modifications and DNA …
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance
N Zhao, C Lai, Y Wang, S Dai, H Gu - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Colorectal cancer (CRC) is one of the deadliest malignancies worldwide, ranking third in
incidence and second in mortality. Remarkably, early stage localized CRC has a 5-year …
incidence and second in mortality. Remarkably, early stage localized CRC has a 5-year …